Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides

Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides New orally bioavailable 2-aminobenzamide-type histone deacetylase inhibitor possessing a (2-hydroxyethyl)(4-(thiophen-2-yl)benzyl)amino group N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: Design, synthesis, SAR studies, and in vivo antitumor activity Synthesis and biological evaluation of aminobenzamides containing purine moiety as class I histone deacetylases inhibitors Identification of novel HDAC inhibitors through cell based screening and their evaluation as potential anticancer agents Discovery of Potent, Isoform-Selective Inhibitors of Histone Deacetylase Containing Chiral Heterocyclic Capping Groups and aN-(2-Aminophenyl)benzamide Binding Unit Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors Discovery of adamantane based highly potent HDAC inhibitors Optimization of biaryl Selective HDAC1&2 Inhibitors (SHI-1:2) Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitors